Christopher Warne, MD
Orthopaedic Surgery · Boise, IDNPI 1093374340
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $14,977 with a category attached, or 66.8%. Smith+Nephew accounts for 67.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $7,757, more than ten times the $345 reported in 2020.
Across 48 payments — averaging $312.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Stryker$2K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$338
- Zimmer Biomet$114
- Medtronic$74
- plus $41 from 1 others
What the payments were for
- Grants$10,00067%
- Travel & lodging$2,11014%
- Food & beverage$2,16714%
- Education$7005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $10,093 |
| Stryker | 23 | $2,459 |
| Medical Device Business Services, Inc. | 14 | $1,858 |
| Johnson & Johnson | 4 | $338 |
| Zimmer Biomet | 2 | $114 |
| Medtronic | 1 | $74 |
| Linkbio Corp | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GAMMA$817
- MAKO$735
- INSIGNIA$563
- NA$559
- ATTUNE$462
- AUGMENT INJECTABLE$154
- AXSOS$154
- VARIAX$154
- HOFFMANN$154
- TFN-Advance$123
How this compares
$14,977 in reported general payments places this provider in the 75th percentile of 139 orthopaedic surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 17 | $176 |
| Oxycodone Hcl | 20 | $66 |
| Tramadol Hcl | 19 | $60 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Boise
- Richard MooreBoise$7.4M
- Roman SchwartsmanBoise$358K
- Jeffry MenznerBoise$194K
- Christopher HiroseBoise$182K
- Joseph LynchBoise$140K
- Tracye LawyerBoise$129K
- Jared JohnsonBoise$82K
- Andrew CurranBoise$34K
- Michael CurtinBoise$33K
- Ronald KristensenBoise$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.